BioSpace News Archive

Business

Nu-Med Plus Announces Keith L. Merrell as Their Full-Time CFO and Secretary/Treasurer

Mr. Merrell brings over 30 years of business and accounting experience while serving as Chief Financial Officer or Controller of five companies both public and private.

February 13, 2018

·

2 min read

Business

Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28

Foamix will host a conference call and webcast at 8:30am Eastern Time on Wednesday, February 28.

February 13, 2018

·

1 min read

Pharm Country

PharmaForce International: Research Indicates Continued Migration Toward Specialty Oncology Sales Forces and Novel Breakthrough Medical Therapy Options for Cancer Patients

This strategic approach is employed in an effort to capitalize on opportunities to increase sales across indications for the same medication.

February 13, 2018

·

2 min read

American Society for Radiation Oncology Release: Nivolumab Immunotherapy Safe and Feasible During Chemoradiation for Advanced Head and Neck Cancer

Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers.

February 13, 2018

·

7 min read

Bionano Genomics Announces Global Launch of its New Direct Labeling Chemistry for Genome Mapping and Structural Variation Analysis - Feb. 13, 2018

On 15 August 2017, Ossur initiated a share buy-back program.

February 13, 2018

·

2 min read

Medtech Titan Boston Scientific Throws $90M Into M

Deals

Exactech Shareholders OK $733M Go-Private Sale to TPG Capital

Upon completion of the transaction, Exactech shareholders will receive $49.25 per share of common stock.

February 13, 2018

·

5 min read

Policy

FDA Permits Marketing of Clinical Decision Support Software for Alerting Providers of a Potential Stroke in Patients

A stroke is a serious medical condition that requires emergency care and can cause lasting brain damage, long-term disability or even death.

February 13, 2018

·

4 min read

Business

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018

Neurocrine Biosciences today announced its financial results for the fourth quarter and year-end of 2017, and provided an update on the launch of INGREZZA and clinical development programs for 2018.

February 13, 2018

·

20 min read

Business

Dynatronics Announces 107.5% Increase in Top Line Sales for Fiscal 2018 Second Quarter

Dynatronics today announced financial results for its fiscal 2018 second quarter ended December 31, 2017.

February 13, 2018

·

8 min read

Drug Development

Exelixis Announces Results from a Phase II Investigator-Sponsored Trial of Cabozantinib in the First-Line Treatment of Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

The results were the subject of a news briefing that took place earlier today and will be presented during an oral session on February 16 starting at 1:30 p.m. MT at the 2018 Multidisciplinary Head and Neck Cancers Symposium, which is being held in Scottsdale, Arizona, February 15–17, 2018.

February 13, 2018

·

14 min read